MedPath

Study of duodenal juice Analysis of the markers in the duodenal juice to detect early stage pancreatic cancer

Phase 2
Conditions
Pancreatic cancer
Registration Number
JPRN-UMIN000015832
Lead Sponsor
Clinical Research Support Center Kyushu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1200
Inclusion Criteria

Not provided

Exclusion Criteria

1) They have no drug hypersensitivity. 2) The doctor-in-charge figures them to be suitable for this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The protein levels in the duodenal juice to detect patients with stage 0/1 pancreatic cancer
Secondary Outcome Measures
NameTimeMethod
The protein levels in the duodenal juice to detect pancreatic cancer and its sensitivity, The protein levels in the duodenal juice to detect pancreatic diseases
© Copyright 2025. All Rights Reserved by MedPath